Nasdaq:ATNX
Athenex, Inc
Last News:
Athenex partner in China on go to launch TAEST therapy studies; shares up 2%
Athenex (ATNX +2.1%) announces that commercialization partner Xiangxue Pharmaceutical Company's subsidiary Xiangxue Life Sciences has received regulatory sign-off in China to start registration studies of T-cell receptor Affinity Enhanced Specific...
